Edwards Lifesciences touts the 1st data on its next-gen Sapien 3 transcatheter heart valve, just as the company pens a wide-ranging TAVI patent settlement deal with arch-rival Medtronic.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oO95Kn
Cap comentari:
Publica un comentari a l'entrada